You just read:

Homology Medicines Presents Data Demonstrating Highly Efficient, On-Target In Vivo Gene Editing Capabilities of its Novel Human-Derived Adeno-Associated Virus Vectors

News provided by

Homology Medicines, Inc.

May 15, 2017, 08:30 ET